9:32AM ET 4/13/2022 MT NewswiresArtelo Biosciences (ARTL) said Wednesday its candidate drug ART27.13 showed "promising pre-clinical results" in protecting human muscle cells from...
10:53AM ET 3/28/2022 MT NewswiresArtelo Biosciences (ARTL) said Monday it agreed to expand its partnership with Trinity College Dublin with a focus on investigating the cellular biology of...
10:34AM ET 3/02/2022 MT NewswiresArtelo Biosciences (ARTL) said Wednesday the US Patent and Trademark Office issued a notice of allowance for a patent application pertaining to ART12.11, a...
9:30AM ET 1/11/2022 MT NewswiresArtelo Biosciences (ARTL) reported that the UK government no longer considers the company's lead clinical cannabinoid ART27.13 a Schedule 1 controlled...